title: Cost-effectiveness of extended-duration antithrombotic prophylaxis after total hip arthroplasty.
authors.forename: Amer
authors.initials: A
authors.lastname: Shoaib
authors.forename: Narlaka
authors.initials: N
authors.lastname: Jayasekera
authors.forename: Monika
authors.initials: M
authors.lastname: Oktaba
authors.forename: Richard T
authors.initials: RT
authors.lastname: Roach
mesh_terms: D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects*; D003362:Cost-Benefit Analysis; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000191:economics*; D006801:Humans; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*; D013997:Time Factors
chemical_list: D005343:Fibrinolytic Agents